Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer’s Disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer’s Disease
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 51, Issue 4, Pages 1085-1097
Publisher
IOS Press
Online
2016-04-13
DOI
10.3233/jad-150937
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PART, a distinct tauopathy, different from classical sporadic Alzheimer disease
- (2015) Kurt A. Jellinger et al. ACTA NEUROPATHOLOGICA
- Prevalence of Amyloid PET Positivity in Dementia Syndromes
- (2015) Rik Ossenkoppele et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts
- (2015) Susan M. Resnick et al. NEUROBIOLOGY OF AGING
- Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease
- (2015) Jon B. Toledo et al. JAMA Neurology
- Associations Between Biomarkers and Age in the Presenilin 1 E280A Autosomal Dominant Alzheimer Disease Kindred
- (2015) Adam S. Fleisher et al. JAMA Neurology
- Primary age-related tauopathy (PART): a common pathology associated with human aging
- (2014) John F. Crary et al. ACTA NEUROPATHOLOGICA
- The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease
- (2014) David A. Drachman Alzheimers & Dementia
- A data-driven model of biomarker changes in sporadic Alzheimer's disease
- (2014) Alexandra L. Young et al. BRAIN
- Rates of -amyloid accumulation are independent of hippocampal neurodegeneration
- (2014) C. R. Jack et al. NEUROLOGY
- The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
- (2014) Reisa Sperling et al. NEURON
- Emerging β-Amyloid Pathology and Accelerated Cortical Atrophy
- (2014) Niklas Mattsson et al. JAMA Neurology
- Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
- (2013) Stephanie JB Vos et al. LANCET NEUROLOGY
- Animal Models of Alzheimer Disease
- (2013) F. M. LaFerla et al. Cold Spring Harbor Perspectives in Medicine
- Soluble A Promotes Wild-Type Tau Pathology In Vivo
- (2012) M. A. Chabrier et al. JOURNAL OF NEUROSCIENCE
- Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease
- (2012) D. S. Knopman et al. NEUROLOGY
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Amyloid-β associated volume loss occurs only in the presence of phospho-tau
- (2011) Rahul S. Desikan et al. ANNALS OF NEUROLOGY
- An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease
- (2011) Clifford R. Jack et al. ANNALS OF NEUROLOGY
- Utility of Combinations of Biomarkers, Cognitive Markers, and Risk Factors to Predict Conversion From Mild Cognitive Impairment to Alzheimer Disease in Patients in the Alzheimer's Disease Neuroimaging Initiative
- (2011) Jesus J. Gomar ARCHIVES OF GENERAL PSYCHIATRY
- Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
- (2011) Heiko Braak et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The pathological process underlying Alzheimer’s disease in individuals under thirty
- (2010) Heiko Braak et al. ACTA NEUROPATHOLOGICA
- Amyloid-β associated cortical thinning in clinically normal elderly
- (2010) J. Alex Becker et al. ANNALS OF NEUROLOGY
- Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis
- (2010) S. W. Pimplikar et al. JOURNAL OF NEUROSCIENCE
- A Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines
- (2010) H. Zempel et al. JOURNAL OF NEUROSCIENCE
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Structural MRI biomarkers for preclinical and mild Alzheimer's disease
- (2009) Christine Fennema-Notestine et al. HUMAN BRAIN MAPPING
- Increasing CSF phospho-tau levels during cognitive decline and progression to dementia
- (2007) Christin Andersson et al. NEUROBIOLOGY OF AGING
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started